| T.R | Title | User | Personal
Name | Date | Lines |
|---|
| 613.1 | and how about circa ? | STOWOA::FERNANDEZ | | Wed Nov 10 1993 13:08 | 4 |
|
Any ideas of how that may effect Circa, who also owns the other 1/2
of Somerset ?
|
| 613.2 | | PARVAX::SCHUSTAK | Who IS John Galt!? | Wed Nov 10 1993 15:34 | 7 |
| Circa (AKA Bolar) has seen a sharp increase in Share value to the $8
-$12 trading range over the last few months. I ASSUME this must be due
to [primarily] the value of Somerset, and [secondarily] to their
gaining some approvals to re-enter generic manufacturing &
distribution.
Steve
|
| 613.3 | Today's WSJ | SWLAVC::HOSSEINI | | Wed Nov 10 1993 18:55 | 15 |
| If you havent' already, read Page B5 of todays' WSJ. Mylan has names a
new CEO, Milan Puskar. Most analysts think that there are chances of
mergers and NOT straight takeover of Mylan. Based on this article,
there are many drug companies talking to each other these days about
mergers and joint ventures. My guess is that both Mylan and Circa will
do good in view of the current health reform debate. I am hearing from
my friends in the industry, that more and more insurance companies
prefer/force you to use generic version of drugs when available.
The idea is that likes of Merk and big guys will want a piece of this
action. The best way to do that is to outright buy or merge with an
exitsing generic drug maker. Mylan might be a good candidate.
Although it is kind of pricy now (at $32).
Hossein_who_had_a_chance_to_buy_MYL_at_24_and_did_not!!
|
| 613.4 | I own 100 shares | CSCMA::BALICH | | Thu Nov 11 1993 10:00 | 3 |
|
I'm hoping for a CIRCA takeover.
|
| 613.5 | News? | SWLAVC::HOSSEINI | | Wed Dec 15 1993 16:37 | 5 |
| Any news on Mylan (NYSE: MYL)? It has come all the way down to $24
(11/15/93's close) from $32 a month ago. I was planning to buy some
but can not get any news.
Thanks,
|
| 613.6 | | VAXCPU::michaud | Jeff Michaud - ObjectBroker | Mon Nov 20 1995 02:14 | 10 |
| Well this topic is a couple of years old...
In any case, Dan Seiver, Editor of the PAD System Report,
recommended this stock on NBR this past Friday night.
Symbol: MYL (MYLAN LABS INC)
Last Trade: 21.3750, Change 0.0000 (0.00%) at Nov 17 4:03:07
Low/High: 21.2500 / 21.5000 (spread 0.2500)
52 Week Low/High: 16.2500 / 24.0000 (spread 7.7500)
Volume/# of Trades: 366300 / 185 (1980 shares/trade)
|
| 613.7 | STILL a great company in a growth industry | NQOS01::nqsrv347.nqo.dec.com::SteveS | Goin' for growth! | Mon Nov 20 1995 13:24 | 7 |
| Just as an FYI, this a split-adjusted value for MYL (3 for 2 about 10-12
months ago.
Still holding this stock...and not compplaining about 20%+/per year in total
returns.
SteveS
|